There is a higher expression level of
epidermal growth factor receptor (EGFR) in up to 90% of advanced
head and neck squamous cell carcinoma (
HNSCC) tissue than in normal surrounding tissues. However, the role of
RNA-binding proteins (RBPs) in EGFR-associated
metastasis of
HNSCC remains unclear. In this study, we reveal that RBPs, specifically
nucleolin (NCL) and
heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2B1), correlated with the mesenchymal phenotype of
HNSCC. The depletion of RBPs significantly attenuated
EGF-induced
HNSCC metastasis. Intriguingly, the
EGF-induced EMT markers, such as
fibronectin, were regulated by RBPs through the ERK and NF-κB pathway, followed by the enhancement of mRNA stability of
fibronectin through the
5' untranslated region (5'-UTR) of the gene. The upregulation of
fibronectin triggered the
integrin signaling activation to enhance
tumor cells' attachment to endothelial cells and increase endothelial permeability. In addition, the concurrence of EGFR and RBPs or EGFR and
fibronectin was associated with overall survival and disease-free survival of
HNSCC. The in vivo study showed that depletion of NCL, hnRNPA2B1, and
fibronectin significantly inhibited
EGF-promoted extravasation of
tumor cells into lung tissues. The depletion of
fibronectin or treatment with
integrin inhibitors dramatically attenuated
EGF-induced
HNSCC metastatic nodules in the lung. Our data suggest that the RBPs/
fibronectin axis is essential for
EGF-induced
tumor-endothelial cell interactions to enhance
HNSCC cell
metastasis.